Sumathi Sivapalasingam

Sumathi Sivapalasingam

Chief Tech/Sci/R&D Officer at UPSTREAM BIO, INC.
Health Technology
Consumer Services

Profile

Sumathi Sivapalasingam is Vice President & Head-Clinical Development at Upstream Bio, Inc. since 2023.
Former roles include Vice President-Translational Medicine at Excision BioTherapeutics, Inc. from 2021 to 2023, Senior Director-Early Clinical Development at Regeneron Pharmaceuticals, Inc. from 2012 to 2021, and Director at New York University School of Medicine.
Education includes undergraduate studies at Swarthmore College and a doctorate from Albert Einstein College of Medicine, Inc.

Sumathi Sivapalasingam active positions

CompaniesPositionStart
UPSTREAM BIO, INC. Chief Tech/Sci/R&D Officer 2022-12-31

Former positions of Sumathi Sivapalasingam

CompaniesPositionEnd
Corporate Officer/Principal 2023-02-28
REGENERON PHARMACEUTICALS, INC. Corporate Officer/Principal 2021-05-31
Director/Board Member -
See the detail of Sumathi Sivapalasingam's experience

Training of Sumathi Sivapalasingam

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

21

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Sumathi Sivapalasingam